March 19, 2020 / 1:03 PM / 21 days ago

BRIEF-Oramed Receives Positive Feedback From End-Of-Phase 2 Oral Insulin Cmc Meeting With FDA

Oramed Pharmaceuticals Inc:

* ORAMED RECEIVES POSITIVE FEEDBACK FROM END-OF-PHASE 2 ORAL INSULIN CMC MEETING WITH FDA

* ORAMED PHARMACEUTICALS INC - EXPECTS AN ADDITIONAL MEETING WITH FDA FOLLOWING DEEPER ANALYSIS OF DATA FROM PHASE 2B TRIAL Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below